Aclaris Therapeutics to Participate in Two September Healthcare Conferences

Rhea-AI Summary

Aclaris Therapeutics (NASDAQ: ACRS), a clinical-stage biopharmaceutical company specializing in immuno-inflammatory diseases, has announced its participation in two major healthcare conferences in September 2025.

CEO Dr. Neal Walker and the senior leadership team will participate in a fireside chat at the Cantor Global Healthcare Conference on September 3 at 1:00 PM EDT. Additionally, Dr. Walker will deliver a corporate presentation at the H.C. Wainwright 27th Annual Global Investment Conference on September 9 at 9:00 AM EDT. Both events will be webcast live and archived on the company's website.

News Market Reaction – ACRS

+0.55%

+0.55% Session close to close

In the Aug 27 session, ACRS gained 0.55%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WAYNE, Pa., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferences in September.

• On Wednesday September 3, 2025, at 1:00 PM EDT, Aclaris’ Chief Executive Officer Dr. Neal Walker and other members of Aclaris’ senior leadership team will participate in a fireside chat during the Cantor Global Healthcare Conference in New York, NY.
  
  
• On Tuesday September 9, 2025, at 9:00 AM EDT, Dr. Walker will provide a corporate presentation during the H.C. Wainwright 27^th Annual Global Investment Conference in New York, NY.
  

Live and archived webcasts of both events will be accessible on the Events page of https://www.aclaristx.com/. The webcasts will be available on the Aclaris website for at least 30 days.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of product candidates powered by a robust R&D engine. For additional information, please visit www.aclaristx.com and follow Aclaris on X (formerly Twitter) at @AclarisTx and on LinkedIn.

Aclaris Therapeutics Contact:

Will Roberts
Senior Vice President
Corporate Communications and Investor Relations
(484) 329-2125
wroberts@aclaristx.com

FAQ

When is Aclaris Therapeutics (ACRS) presenting at the Cantor Global Healthcare Conference 2025?

Aclaris will participate in a fireside chat at the Cantor Global Healthcare Conference on September 3, 2025, at 1:00 PM EDT in New York.

What time is Aclaris Therapeutics' presentation at the H.C. Wainwright Conference?

Dr. Neal Walker will present at the H.C. Wainwright Conference on September 9, 2025, at 9:00 AM EDT in New York.

Where can I watch Aclaris Therapeutics' (ACRS) conference presentations?

The presentations can be accessed through live and archived webcasts on the Events page of www.aclaristx.com. The recordings will be available for at least 30 days.

Who will be presenting for Aclaris Therapeutics at these healthcare conferences?

Dr. Neal Walker, CEO of Aclaris, will present at both conferences. The Cantor conference presentation will also include other members of the senior leadership team.